AdvaMed Praises Senate Introduction of FDA Legislation
WASHINGTON , DC – Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), released the following statement about the “Medical Device Regulatory Improvement Act,” sponsored by Sen. Amy Klobuchar (D-MN) and cosponsored by Sens. Richard Burr (R-NC) and Michael Bennett (D-CO), which was introduced in the U.S. Senate today:
“AdvaMed applauds Sen. Klobuchar, along with her cosponsors Sen. Burr and Sen. Bennett, for their bipartisan work on this important legislation that will help American patients to get timely access to life-saving, life-changing medical technology. We are especially encouraged to see the legislation’s focus on clarifying FDA data requirements, streamlining agency management processes, and its emphasis on the importance of attracting the best experts to FDA advisory committees.
“We support the legislation and commend the bill’s sponsors for working to make the FDA review process more efficient and predictable, a key component of AdvaMed’s Competitiveness Agenda.
“As the legislative process moves forward we look forward to working with members of Congress on both sides of the aisle, and with FDA to ensure patients have timely access to safe and effective products.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.